OPKO Health Inc (NASDAQ:OPK)

3.85
Delayed Data
As of Feb 16
 -0.11 / -2.78%
Today’s Change
3.61
Today|||52-Week Range
8.92
-21.43%
Year-to-Date
Weekly CEO Buys Highlight
Feb 12 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close3.96
Today’s open3.95
Day’s range3.83 - 3.98
Volume2,463,511
Average volume (3 months)4,523,177
Market cap$2.2B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-422.48%
Earnings growth (next 5 years)+70.80%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.27-0.56%
CLVSClovis Oncology Inc-0.43-0.79%
PBYIPuma Biotechnology I...-1.05-1.54%
MNKMallinckrodt Plc+0.06+0.36%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts